How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Public Health Archives

Early Release – Age Differences in Pertussis Epidemics, New South Wales, Australia, 2015 and 2024 – Volume 32, Number 10—October 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

September 23, 2026 No Comments

As Health Insurance Costs Soar, Healthcare Workers Also Feel the Pinch

BOISE, Idaho — Joshua and Ashley Durham run a family medicine practice, and for the

September 22, 2026 No Comments

Study shows high need for respiratory support in patients with severe Andes hantavirus infections

blanscape / iStock Older children diagnosed as having complex critical conditions (CCCs) carry a greater

September 22, 2026 No Comments

Early Release – Cocirculation of Human Monkeypox Virus Clade 1b with Varicella Zoster Virus, Uganda – Volume 32, Number 10—October 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

September 22, 2026 No Comments

Early Release – Age Differences in Pertussis Epidemics, New South Wales, Australia, 2015 and 2024 – Volume 32, Number 10—October 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

September 22, 2026 No Comments

ECDC deploys experts to DRC to increase support amidst ongoing Ebola outbreak

“ECDC is increasing its presence on the ground to contribute to an effective response to

September 21, 2026 No Comments

Voss: Zoonotic diseases, part 2

One of the side effects of having a veterinarian who also studied public health is

September 21, 2026 No Comments

Early Release – Genomic Epidemiology of Salmonella enterica Serovar Hadar Strain Linked to Poultry-Associated Salmonellosis Outbreaks, United States – Volume 32, Number 10—October 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

September 21, 2026 No Comments

Early Release – Cocirculation of Human Monkeypox Virus Clade 1b with Varicella Zoster Virus, Uganda – Volume 32, Number 10—October 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

September 21, 2026 No Comments

Yellow Fever in Colombia – Level 2 – Level 2 – Practice Enhanced Precautions – Travel Health Notices | Travelers’ Health

Yellow fever is a severe viral disease with jaundice and hemorrhagic manifestations that is spread through

September 20, 2026 No Comments

Early Release – Age Differences in Pertussis Epidemics, New South Wales, Australia, 2015 and 2024 – Volume 32, Number 10—October 2026 – Emerging Infectious Diseases journal

As Health Insurance Costs Soar, Healthcare Workers Also Feel the Pinch

Study shows high need for respiratory support in patients with severe Andes hantavirus infections

Early Release – Cocirculation of Human Monkeypox Virus Clade 1b with Varicella Zoster Virus, Uganda – Volume 32, Number 10—October 2026 – Emerging Infectious Diseases journal

Early Release – Age Differences in Pertussis Epidemics, New South Wales, Australia, 2015 and 2024 – Volume 32, Number 10—October 2026 – Emerging Infectious Diseases journal

ECDC deploys experts to DRC to increase support amidst ongoing Ebola outbreak

Voss: Zoonotic diseases, part 2

Early Release – Genomic Epidemiology of Salmonella enterica Serovar Hadar Strain Linked to Poultry-Associated Salmonellosis Outbreaks, United States – Volume 32, Number 10—October 2026 – Emerging Infectious Diseases journal

Early Release – Cocirculation of Human Monkeypox Virus Clade 1b with Varicella Zoster Virus, Uganda – Volume 32, Number 10—October 2026 – Emerging Infectious Diseases journal

Yellow Fever in Colombia – Level 2 – Level 2 – Practice Enhanced Precautions – Travel Health Notices | Travelers’ Health

Schedule an Appointment

Quick Links

Patient Forms

Contact Us